LSW Event

Founded in 2011, Absci has grown from a basement lab at Portland State University’s business accelerator into a publicly traded leader in AI-driven drug discovery. Under founder and CEO Sean McClain, the company progressed from a 2016 Series A to a 2021 IPO on NASDAQ with a $2B market cap, and now operates from an […]

With the recent reauthorization of the Small Business Innovation Research (SBIR) program, now is a critical time for life science companies to revisit non-dilutive funding opportunities. Applying for grants can be an overwhelming process, let us make it easier for you! On May 19, join us for a free virtual workshop where Natalie Rudolph and […]

Johnson & Johnson is advancing transformative innovation across drug discovery, drug development, data science, and digital health to accelerate the delivery of breakthrough therapies. Our approach is grounded in deep biological insight and an appreciation of disease complexity, enabling the development of novel, differentiated medicines. We leverage broad expertise across modalities—including small molecules, multispecific antibodies, […]

From the Laboratory to Leadership program develops the skills and knowledge of first time and developing managers in life science companies, taking them from competent technical managers to capable business leaders.

Strategic partnerships are essential for accelerating innovation, bridging the gap between scientific discovery and commercialization, and navigating complex market dynamics. Join us in person for this Executive Insight Series session, focused on navigating early-stage partnerships and collaborations in life sciences. Lila Hope, Partner at Cooley, and Jie D’Elia, CEO of Systimmune, will explore the mechanics […]